arXiv Machine Learning By Octavia-Andreea Ciora, Julian Welzel, Dennis Frauen, Maresa Schr\"oder, Marie Brockschmidt, Harry Amad, Thomas Callender, Mihaela van der Schaar, Stefan Feuerriegel

OncoSynth: Synthetic data generation for treatment effect estimation in oncology

Read the original on arXiv Machine Learning →

arXiv:2606. 25762v1 Announce Type: new Abstract: In oncology, access to patient-level data is often restricted.

Machine-generated by The Flow from the publisher's headline and feed description — not written or checked by a human. The full article lives at arXiv Machine Learning.

arXiv AI
Sep 15

Causal multi-modal AI for personalized chemosensitivity prediction

A causal multi-modal AI model was developed to predict personalized chemosensitivity in breast cancer patients using routine pathology and clinical data. Trained on 9,141 patients from nine countries and validated on 1,994 patients from three countries, the model produced treatment-specific recurrence probabilities with near-perfect calibration and strong prognostic discrimination over 5- and 10-year horizons. It outperformed existing recurrence-score tests and could reduce chemotherapy prescriptions by 30% while maintaining recurrence-free rates, with predictive performance also transferring to non-breast cancers.

By Dhruva Biswas, Jeroen Berrevoets, Alec McClean, Linus Bao, Jungkyu Park, Ken G. Zeng, Joseph Cappadona, Cerise Tang, Chuwen Liu, Bartosz Machura, Yin Wu, Valerie Speirs, Hatem Soliman, Rohit Bhargava, Sheheryar Kabraji, Thaer Khoury, David Page, Brian Piening, Carlo Bifulco, Claudia Meurs, Pieter Westenend, Sylvie Chabaud, Jerome Lemonnier, Paul H. Cottu, Florence Dalenc, Fabrice Andre, Frederique Madeleine Penault-Llorca, Thomas Bachelot, Frederick Howard, Francisco J. Esteva, Kevin Kalinsky, Lajos Pusztai, Jan Witowski, Krzysztof J. Geras
arXiv Machine Learning
Sep 24

Artificial intelligence surrogates for treatment effect estimation with before-and-after data

The paper proposes a method for estimating treatment effects using AI-generated predictions as surrogates, applied to paired before-and-after measurements for each treated individual. By comparing AI predictions before and after treatment, the approach can identify the average treatment effect on the treated under certain technical assumptions, even when clinical outcomes are never observed for treated subjects. When assumptions are questionable, the authors introduce prediction‑powered inference that corrects bias with a small set of observed outcomes, and validate the method with synthetic and cardio‑oncology data.

By Frances Dean, Anna Neufeld, Joshua Barrios, Geoffrey H Tison, Ahmed Alaa